Image For Activity Cover
Virtual Tumor Board: Sarcoma Disease-September 2020
Activity Overview
In this tumor board, participants will learn through case-based discussions about:

  1. Recognizing the potential role of chemotherapy in the multimodality management of STS patients
  2. Differentiating the pros and cons of neoadjuvant versus postoperative chemotherapy in the treatment of a primary STS
  3. Identifying potential candidates for chemotherapy based upon level of metastatic risk, age, and comorbidities.
  4. Summarizing common chemotherapy regimens used for STS neoadjuvant/adjuvant therapy (drugs, number of cycles)
  5. Distinguishing variables (disease biology, patient factors) that determine the potential role of chemotherapy in the management of oligometastatic disease

Moderator is John Kane, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Panelists are
Kenneth Cardona, MD, Emory University, Winship Cancer Institute, Atlanta, GA
Chee-Chee H. Stucky, MD, Mayo Clinic Arizona, Phoenix, AZ
Maria Alejandra Zarzour, MD, MD Anderson Cancer Center, Houston, TX
Summary
Availability: On-Demand
Cost: FREE
Credit Offered: No Credit Offered
Powered By